J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4S):S91-S104. doi: 10.1016/j.japh.2021.01.016. Epub 2021 Feb 6.
The primary study objective was to characterize community pharmacist preceptors' experience, clinical and legislative knowledge, attitudes, and behaviors regarding cannabidiol (CBD). The secondary study objective was to identify which of these factors influenced intent to recommend CBD products.
A 36-item survey was used to collect respondent demographics, experience, knowledge, attitudes, and behaviors regarding CBD. Items assessing attitudes, behaviors, and intent were developed using the Theory of Planned Behavior (TPB). Community pharmacist preceptors for schools of pharmacy across the United States were eligible to complete an electronic survey open for 12 weeks from January to April 2020. Descriptive statistics were used to summarize respondent demographics, experience, knowledge, and TPB constructs. Ordinal logistic regression was used to evaluate which factors influenced intent.
The survey was disseminated to an estimated 2242 community pharmacist preceptors and received 295 responses (13.2% response rate). Of the 272 respondents who met eligibility criteria to progress through the survey, the survey was completed in its entirety by 236 respondents (86.8% completion rate). For experience items, most respondents (70.7%) reported receiving previous education on CBD. Almost half (48.4%) reported CBD sales in their pharmacies, whereas 89.1% reported answering clinical questions about CBD. For knowledge items, respondents performed poorly on CBD adverse effect and drug interaction items. Many respondents were not comfortable counseling on (49.0%) or recommending (56.1%) CBD products for patient use. Most (74.5%) believed more research was needed before they would feel comfortable recommending CBD products. Most (57.8%) reported not having reliable CBD resources available in their pharmacies. Subjective norms and previous CBD education or personal research were the only factors found to have direct influences on respondents' intent to recommend CBD products.
Opportunities exist to fill knowledge gaps, enhance confidence, and provide desired educational resources for community pharmacist preceptors on CBD products.
主要研究目的是描述社区药剂师导师在大麻二酚（CBD）方面的经验、临床和立法知识、态度和行为。次要研究目的是确定这些因素中的哪些因素影响推荐 CBD 产品的意愿。
采用 36 项调查问卷收集受访者关于 CBD 的人口统计学、经验、知识、态度和行为。评估态度、行为和意愿的项目是使用计划行为理论（TPB）开发的。美国各药学学校的社区药剂师导师有资格完成一项从 2020 年 1 月至 4 月为期 12 周的电子调查。使用描述性统计数据总结受访者的人口统计学、经验、知识和 TPB 结构。有序逻辑回归用于评估哪些因素影响意愿。
该调查分发给估计有 2242 名社区药剂师导师，并收到 295 份回复（13.2%的回复率）。在符合参与调查条件的 272 名受访者中，有 236 名（86.8%的完成率）完整完成了调查。在经验项目方面，大多数受访者（70.7%）表示之前接受过 CBD 教育。近一半（48.4%）报告在他们的药店销售 CBD，而 89.1%报告回答过关于 CBD 的临床问题。在知识项目方面，受访者在 CBD 不良反应和药物相互作用项目上表现不佳。许多受访者对（49.0%）或推荐（56.1%）CBD 产品用于患者使用感到不舒服。大多数（74.5%）认为在他们感到舒适推荐 CBD 产品之前需要进行更多的研究。大多数（57.8%）报告在他们的药店没有可靠的 CBD 资源。主观规范以及之前关于 CBD 的教育或个人研究是唯一被发现对受访者推荐 CBD 产品的意愿有直接影响的因素。
有机会填补社区药剂师导师在 CBD 产品方面的知识空白、增强信心并提供所需的教育资源。
